Page 1 | Search Results | Blood | American Society of Hematology

Skip Nav Destination

1-16 of 16

Sort by

Sort Order Select

Journal Articles

Outcomes of Patients with Extranodal Natural Killer/T-Cell Lymphoma: Single Institution Series

Blood (2021) 138 (Supplement 1): 4536.

https://doi.org/10.1182/blood-2021-154347

Published: 2021

Journal Articles

Serum Albumin and Neutrophil-to-Lymphocyte Ratio, Two Independent Factor Predicting Survival in Patients with Follicular Lymphoma: A Multi-Institutional Retrospective Cohort of 741 FL, from the Latin American Lymphoproliferative Study Group (GELL)

Blood (2021) 138 (Supplement 1): 4515.

https://doi.org/10.1182/blood-2021-149662

Published: 2021

Journal Articles

Phase II Trial of Response Adapted Ultra Low Dose (ULD) Orbital Radiation Therapy for Indolent B Cell Lymphoma

Blood (2021) 138 (Supplement 1): 3526.

https://doi.org/10.1182/blood-2021-154172

Published: 2021

Journal Articles

Ibrutinib Plus Rituximab and Venetoclax (IRV) Followed By Risk-Stratified Observation or Short Course R-Hypercvad/MTX in Young Patients with Previously Untreated Mantle Cell Lymphoma - Phase-II Window-2 Clinical Trial

Blood (2021) 138 (Supplement 1): 3525.

https://doi.org/10.1182/blood-2021-153390

Published: 2021

Journal Articles

Clinico-Epidemiological Features of Elderly Patients with Peripheral T-Cell Lymphoma Not Otherwise Specified: A Study from the Grupo De Estudio Latinoamericano De Linfoproliferativos (GELL)

Henry Idrobo, Denisse Castro, Lorena Fiad, Yesenia M. Huerta- Collado, Victoria Otero, Sally Rose Paredes, Juan Esteban Garcia-Robledo, Juan Felipe Lasso, Humberto Martinez-Cordero, Ana Maria Osorio-Gomez, Julian Andres Sanchez-Perea, Bryan Valcarcel, Luis Villela, Marialejandra Alejandra Torres Viera, Brady E Beltran, Jorge J. Castillo, Luis Malpica-Castillo

Blood (2021) 138 (Supplement 1): 2468.

https://doi.org/10.1182/blood-2021-153849

Published: 2021

Journal Articles

Evaluating the Prognostic Value of Inflammatory Biomarkers and Traditional Prognostic Tools in PTCL: A National, Multicenter Retrospective Study

Sally Rose Paredes, Denisse Castro, Thanya Runciman, Yesenia M. Huerta- Collado, Brady E Beltran, Marco Antonio Zuñiga, Jorge J. Castillo, Bryan Valcarcel, Luis Malpica Castillo

Blood (2021) 138 (Supplement 1): 2474.

https://doi.org/10.1182/blood-2021-152414

Published: 2021

Journal Articles

Long Term Outcome Patterns and Risk Factors for Early Mortality and Disease Progression in ALK-Positive Anaplastic Large Cell Lymphoma

Blood (2021) 138 (Supplement 1): 2463.

https://doi.org/10.1182/blood-2021-150798

Published: 2021

Journal Articles

A Simplified Novel Prognostic Score to Predict Early Mortality and Disease Progression in Patients with Aggressive Adult T-Cell Leukemia/Lymphoma

Bryan Valcarcel, Denisse Castro, Daniel J Enriquez, Camila Peña, Henry Idrobo, Lorena Fiad, Maria Prates, Sally Rose Paredes, Marialejandra Alejandra Torres Viera, Guilherme Fleury Perini, Jorge J. Castillo, Luis Villela, Brady E Beltran, Juan Carlos Ramos, Luis Malpica-Castillo

Blood (2021) 138 (Supplement 1): 1404.

https://doi.org/10.1182/blood-2021-151278

Published: 2021

Journal Articles

Outcome of Patients with T- Cell Histiocyte Rich B Cell Lymphoma: Single Institution Series

Blood (2021) 138 (Supplement 1): 1448.

https://doi.org/10.1182/blood-2021-154035

Published: 2021

Journal Articles

A Novel Prognostic Index for Patients with EBV-DLBCL NOS: A Study from the Grupo De Estudio Latinoamericano De Linfoproliferativos (GELL)

Blood (2021) 138 (Supplement 1): 1436.

https://doi.org/10.1182/blood-2021-151389

Published: 2021

Journal Articles

Clinicopathological Features and Outcomes of EBV Positive and Negative DLBCL: A Study from the Grupo De Estudio Latinoamericano De Linfoproliferativos (GELL)

Blood (2021) 138 (Supplement 1): 1442.

https://doi.org/10.1182/blood-2021-152340

Published: 2021

Journal Articles

Updated Analysis Confirms Sustained Poor Prognosis of COVID-19 in Patients with Lymphoma in Latin America: A Cohort of 160 Patients from Gell

Blood (2021) 138 (Supplement 1): 2520.

https://doi.org/10.1182/blood-2021-153875

Published: 2021

Journal Articles

Biological and Classical Prognostic Factors with Impact on Overall Survival in Patients with Early Stage (I/II) Diffuse Large B-Cell Lymphoma: A Study from the Grupo De Estudio Latinoamericano De Linfoproliferativos (GELL)

Blood (2021) 138 (Supplement 1): 2516.

https://doi.org/10.1182/blood-2021-152724

Published: 2021

Journal Articles

Incidence and Outcome of Acute Myeloid Leukemia in Peru: An 11-Year Single Center Experience

Ali Al-kassab-Córdova, Lizbeth Lachira-Yparraguirre, Gustavo Sandival-Ampuero, MD, Katia Roque, MD, Emperatriz Ortega, MD, Sofia Lozano-Ballena, MD, Juan C Haro, MD, Shirley Quintana, MD, Marco Villena, MD, Greenlandia Ferreyros-Brandon, MD, Juan L Garcia-Leon, MD, Cesar Samanez-Figari, MD, Luis Malpica Castillo, MD, Daniel J Enriquez, MD

Blood (2020) 136 (Supplement 1): 28–29.

https://doi.org/10.1182/blood-2020-143373

Published: 2020

Journal Articles

Proposal of a Novel Latin American International Prognostic Index (LATAM-IPI) for Diffuse Large B-Cell Lymphoma (DLBCL) By the Grupo Para El Estudio De Linfoproliferativos En Latino-America (GELL)

Luis Villela Villela, MDMC, Ana Ramirez-Ibarguen, MD, Brady E Beltran, MD, Camila Peña, MD, Denisse A. Castro, MD, Gladys P Agreda-Vasquez, MD, Myrna Candelaria, MDPharmD, Maria Alejandra Torres Viera, MD, Henry Idrobo, MD, Lorena Fiad, MD, Fabiola Valvert, MD, Efreen Montaño Figueroa, MD PhD, Juan Ospina Idarraga, Alana Von Glasenapp, MD, Sally Paredes, MD, Melani Otañez, MD, Fernando Perez-Jacobo, Daniela Zambrano, Humberto Martínez Cordero, MD, Virginia Otero, MD, Lidiane Andino, Mercedes Royg Arriola, MD, Maria Elvira Enciso, MD, Maria Prates, MD, Cristaldo Nancy, MD, Ivan Perdomo, MD, Maria E Cabrera, MD, María Lorena Cardozo, MD, Cristobal Augusto Frutos Ortiz, MD, Eloisa Riva, MD, Juan Antonio Choque, MD, Alfredo Reinaldo Quiroz, MD, Guilherme Fleury Perini, MD, David Gomez-Almaguer, MD, Guillermo J. Ruiz-Arguelles, FRCP, MACP, Marcos Distefano, Katerine Garcia, Carolina Feres, MD, Mariana Kalmus, Julian Cordova, Magali DelosRios, MD, Rosio Baena, MD, Luis Malpica Castillo, MD, Eduardo Sotomayor, MD, Jorge J. Castillo, MD

Blood (2020) 136 (Supplement 1): 25–27.

https://doi.org/10.1182/blood-2020-142836

Published: 2020

Journal Articles

COVID-19 in Patients with Lymphoma: A Grupo De Estudio Latinoamericano En Linfoproliferativos (GELL) Retrospective Study

Guilherme Fleury Perini, MD, Juan Alejandro Ospina Idarraga, Maria Alejandra Torres Viera, MD, Brady E Beltran, MD, Denisse A. Castro, MD, Victoria Otero, MD, Mariana Kalmus, Lorena Fiad, MD, Camila Peña, MD, Henry Idrobo, MD, Myrna Candelaria, MDPharmD, Alana Von Glasenapp, MD, Ivan Perdomo, MD, Carolina Feres, MD, Maria Prates, MD, Sally Rose Paredes, MD, Fernando Pérez-Jacobo, MD, Ana Ramirez-Ibarguen, MD, Claudia Gajardo, MD, Macarena Alejandra Roa Salinas, Humberto Martínez Cordero, MD, Melani Otañez, MD, Fabiola Valvert, MD, Efreen Montaño Figueroa, MD PhD, Marcos Di Stefano, MD, Rosio Baena, MD, Juan Antonio Choque, MD, Virginia Abello, MD, Ximena Valladares, MD, Sofia Sanchez, MD, Cristaldo Nancy, MD, Daniela Zambrano, Juan Felipe Lasso, MD, Andrea Noboa, MD, Christine Rojas, MD, Larissa LC Teixeira, Luis Malpica Castillo, MD, Eduardo Sotomayor, MD, Jorge J. Castillo, MD, Luis Villela Villela, MDMC

Blood (2020) 136 (Supplement 1): 35–36.

https://doi.org/10.1182/blood-2020-142787

Published: 2020

NARROW

Outcomes of Patients with Extranodal Natural Killer/T-Cell Lymphoma: Single Institution Series

Serum Albumin and Neutrophil-to-Lymphocyte Ratio, Two Independent Factor Predicting Survival in Patients with Follicular Lymphoma: A Multi-Institutional Retrospective Cohort of 741 FL, from the Latin American Lymphoproliferative Study Group (GELL)

Phase II Trial of Response Adapted Ultra Low Dose (ULD) Orbital Radiation Therapy for Indolent B Cell Lymphoma

Ibrutinib Plus Rituximab and Venetoclax (IRV) Followed By Risk-Stratified Observation or Short Course R-Hypercvad/MTX in Young Patients with Previously Untreated Mantle Cell Lymphoma - Phase-II Window-2 Clinical Trial

Clinico-Epidemiological Features of Elderly Patients with Peripheral T-Cell Lymphoma Not Otherwise Specified: A Study from the Grupo De Estudio Latinoamericano De Linfoproliferativos (GELL)

Evaluating the Prognostic Value of Inflammatory Biomarkers and Traditional Prognostic Tools in PTCL: A National, Multicenter Retrospective Study

Long Term Outcome Patterns and Risk Factors for Early Mortality and Disease Progression in ALK-Positive Anaplastic Large Cell Lymphoma

A Simplified Novel Prognostic Score to Predict Early Mortality and Disease Progression in Patients with Aggressive Adult T-Cell Leukemia/Lymphoma

Outcome of Patients with T- Cell Histiocyte Rich B Cell Lymphoma: Single Institution Series

A Novel Prognostic Index for Patients with EBV-DLBCL NOS: A Study from the Grupo De Estudio Latinoamericano De Linfoproliferativos (GELL)

Clinicopathological Features and Outcomes of EBV Positive and Negative DLBCL: A Study from the Grupo De Estudio Latinoamericano De Linfoproliferativos (GELL)

Updated Analysis Confirms Sustained Poor Prognosis of COVID-19 in Patients with Lymphoma in Latin America: A Cohort of 160 Patients from Gell

Biological and Classical Prognostic Factors with Impact on Overall Survival in Patients with Early Stage (I/II) Diffuse Large B-Cell Lymphoma: A Study from the Grupo De Estudio Latinoamericano De Linfoproliferativos (GELL)

Incidence and Outcome of Acute Myeloid Leukemia in Peru: An 11-Year Single Center Experience

Proposal of a Novel Latin American International Prognostic Index (LATAM-IPI) for Diffuse Large B-Cell Lymphoma (DLBCL) By the Grupo Para El Estudio De Linfoproliferativos En Latino-America (GELL)

COVID-19 in Patients with Lymphoma: A Grupo De Estudio Latinoamericano En Linfoproliferativos (GELL) Retrospective Study

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only